Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 2 art units • 4 examiners • 0 of 8 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Encapsys LLC currently manages 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These filings are distributed among 4 distinct examiners and 2 distinct art units. The concentration of 6 actions within 2 art units suggests a technical scope for the company's current patent applications. This focus allows for a consistent understanding of the technical field across the different pending matters.
PHAN, DOAN THI-THUC is the busiest examiner for this portfolio, holding 3 busiest examiner pending actions. This means a single examiner is responsible for a portion of the 6 pending office actions. With 4 distinct examiners in total, the remaining actions are divided among the other individuals, highlighting the influence of PHAN, DOAN THI-THUC on the portfolio's progress. The fact that 3 actions are concentrated with a single examiner while the portfolio spans the distinct art units suggests that this examiner is a key figure in the company's prosecution strategy. Practitioners should prioritize understanding the specific tendencies of this busiest examiner.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 3 (38%) |
| Multi-statute (no §101) | 5 (62%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, DOAN THI-THUC | 5 | 42.7% | +47.7% |
| OGDEN JR, NECHOLUS | 1 | 69.8% | +23.5% |
| DELCOTTO, GREGORY R | 1 | 54.0% | +75.8% |
| GOTFREDSON, GAREN | 1 | 40.0% | +28.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554018 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | PHAN, DOAN THI-THUC | 43d overdue |
| 18462537 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | PHAN, DOAN THI-THUC | 43d overdue |
| 18475472 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | PHAN, DOAN THI-THUC | 16d overdue |
| 18874388 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | OGDEN JR, NECHOLUS | — |
| 18252822 | BIODEGRADABLE DELIVERY PARTICLES | PHAN, DOAN THI-THUC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554018 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | PHAN, DOAN THI-THUC | 43d overdue |
| 18462537 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | PHAN, DOAN THI-THUC | 43d overdue |
| 18475472 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | PHAN, DOAN THI-THUC | 16d overdue |
| 18874388 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | OGDEN JR, NECHOLUS | — |
| 18872341 | TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES | DELCOTTO, GREGORY R | — |
| 18771223 | MULTIFUNCTIONAL (METH)ACRYLATE POLYSACCHARIDE MICROCAPSULES | GOTFREDSON, GAREN | — |
| 18252835 | BIODEGRADABLE DELIVERY PARTICLES | PHAN, DOAN THI-THUC | — |
| 18252822 | BIODEGRADABLE DELIVERY PARTICLES | PHAN, DOAN THI-THUC | — |
| Art Unit | Apps |
|---|---|
| 1613 | 5 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18874388 | TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES | OGDEN JR, NECHOLUS | — | §102§112 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18872341 | TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES | DELCOTTO, GREGORY R | — | §102§112DP | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18771223 | MULTIFUNCTIONAL (METH)ACRYLATE POLYSACCHARIDE MICROCAPSULES | GOTFREDSON, GAREN | 1619 | §103§112DP | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18554018 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | PHAN, DOAN THI-THUC | 1613 | §102§103§112Other | Final Rejection | 43d overdue | Pending | Oct 05, 2023 |
| 18475472 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | PHAN, DOAN THI-THUC | 1613 | §103§112 | Final Rejection | 16d overdue | Pending | Sep 27, 2023 |
| 18462537 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | PHAN, DOAN THI-THUC | 1613 | §102§103§112Other | Final Rejection | 43d overdue | Pending | Sep 07, 2023 |
| 18252835 | BIODEGRADABLE DELIVERY PARTICLES | PHAN, DOAN THI-THUC | 1613 | §103§112DP | Non-Final OA | — | Pending | May 12, 2023 |
| 18252822 | BIODEGRADABLE DELIVERY PARTICLES | PHAN, DOAN THI-THUC | 1613 | §103§112 | Non-Final OA | — | Pending | May 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial